Abstract
Metabolic syndrome X is an inflammatory condition. Increased consumption of high-energy diet, saturated and trans-fats by pregnant women and lactating mothers suppresses the activities of enzymes Δ6 and Δ5 desaturases in maternal and fetal tissues resulting in a decrease in the concentrations of long-chain polyunsaturated fatty acids (LCPUFAs) such as arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). These LCPUFAs have a regulatory role on inflammation. EPA, DHA, and AA augment eNO synthesis, augment insulin action both in the peripheral tissues and brain, and are critical for brain growth and development, synaptogenesis, and modulate the action of neurotransmitters and hypothalamic peptides. These evidences suggest that sub-optimal LCPUFAs during perinatal period could initiate low-grade systemic inflammation and development of metabolic syndrome X in these children if they continue to consume energy dense diet. This implies that perinatal supplementation of LCPUFAs could aid to prevent, arrest or postpone the development of metabolic syndrome X.
Keywords: manganese superoxide dismutase, tumor necrosis factor alpha, coronary heart disease, C-reactive protein, noradrenaline
Current Nutrition & Food Science
Title: Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Volume: 3 Issue: 4
Author(s): Undurti N. Das
Affiliation:
Keywords: manganese superoxide dismutase, tumor necrosis factor alpha, coronary heart disease, C-reactive protein, noradrenaline
Abstract: Metabolic syndrome X is an inflammatory condition. Increased consumption of high-energy diet, saturated and trans-fats by pregnant women and lactating mothers suppresses the activities of enzymes Δ6 and Δ5 desaturases in maternal and fetal tissues resulting in a decrease in the concentrations of long-chain polyunsaturated fatty acids (LCPUFAs) such as arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). These LCPUFAs have a regulatory role on inflammation. EPA, DHA, and AA augment eNO synthesis, augment insulin action both in the peripheral tissues and brain, and are critical for brain growth and development, synaptogenesis, and modulate the action of neurotransmitters and hypothalamic peptides. These evidences suggest that sub-optimal LCPUFAs during perinatal period could initiate low-grade systemic inflammation and development of metabolic syndrome X in these children if they continue to consume energy dense diet. This implies that perinatal supplementation of LCPUFAs could aid to prevent, arrest or postpone the development of metabolic syndrome X.
Export Options
About this article
Cite this article as:
Das N. Undurti, Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period, Current Nutrition & Food Science 2007; 3 (4) . https://dx.doi.org/10.2174/1573401310703040277
DOI https://dx.doi.org/10.2174/1573401310703040277 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Current Pharmaceutical Design Actions of Rho-Kinase Inhibitors in Cardiovascular Diseases
Current Enzyme Inhibition Hypereosinophilic Syndrome, Churg-Strauss Syndrome and Parasitic Diseases: Possible Links between Eosinophilia and Thrombosis
Current Vascular Pharmacology An Umbrella Review of Nuts Intake and Risk of Cardiovascular Disease
Current Pharmaceutical Design Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Editorial (Thematic Issue: Is The Female Heart Exposed To Cardiovascular Disease?)
Current Medicinal Chemistry The Coronary Collateral Circulation in Man
Current Cardiology Reviews Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
Current Drug Targets Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Choosing a Revascularization Strategy in Patients with Diabetes and Stable Coronary Artery Disease: A Complex Decision
Current Cardiology Reviews Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology The Effect of Risk Factor Changes on Peripheral Arterial Disease and Cardiovascular Risk
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention
Current Vascular Pharmacology Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Pro-Angiogenic Effect of Endomyocardial Biopsy-Derived Cells for Cardiac Regeneration
Current Tissue Engineering (Discontinued) Role of Sulfur Containing Amino Acids as an Adjuvant Therapy in the Prevention of Diabetes and its Associated Complications
Current Diabetes Reviews The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Pharmacogenetics of Statins Therapy
Recent Patents on Cardiovascular Drug Discovery Safety of Inhaled Corticosteroids. Why the Variation in Systemic Adverse Effects?
Current Pediatric Reviews